Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05715242
Other study ID # 68892
Secondary ID P30DK116074
Status Completed
Phase N/A
First received
Last updated
Start date December 5, 2023
Est. completion date April 14, 2024

Study information

Verified date April 2024
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this pilot trial is to learn about the optimal intensity level of goals in a digital weight loss intervention among adults with overweight or obesity. The main questions of the study are to assess the feasibility and acceptability of different goal intensities across four domains (calorie goal, step goal, eating window goal, red zone food goal). The investigators will recruit 32 total participants to the trial. Recruitment will occur through remote channels. Interested individuals will be directed to an online screening questionnaire; those who are eligible will then be invited to attend an initial remote session with study personnel to ensure interest and eligibility in the study. The weight loss intervention will last 10 weeks, and all participants will receive a "core" treatment consisting of self-monitoring weight, food intake, and steps (all via digital tools provided by the study team), along with behavioral lessons, action plans, and tailored feedback. Depending on which group participants are assigned to in the study, individuals will receive either a more or less challenging goal across the four domains. All study tasks will occur remotely, thus, participants will never come in-person for any tasks. Assessment of body weight and other measures will occur at the beginning of the trial ("baseline"), and at 4 weeks and 10 weeks. The investigators will use the Multiphase Optimization Strategy (MOST) framework to identify which of the goal intensity levels result in meaningful engagement and weight loss. The current study is the first step towards answering this question; it is designed as a pilot factorial trial, which focuses on feasibility and acceptability. In total, there will be 16 treatment conditions.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date April 14, 2024
Est. primary completion date April 9, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adults (ages 18+ years) - body mass index (BMI) 25.0 to 45.0 kg/m^2 - smartphone ownership - willingness to install the Fitbit mobile app on their phone - access to a personal email account - English language proficiency - interest in losing weight through behavioral strategies - living in the United States Exclusion Criteria: - concurrent enrollment in another weight management intervention - loss of =10 lbs. in the past 6 months - current use of a weight loss medication - prior or planned bariatric surgery - current or planned pregnancy in the trial period - currently breastfeeding - lives with someone else participating in the study - hospitalization for a mental health condition in the past 12 months - inability to engage in moderate forms of physical activity akin to brisk walking (assessed by the Physical Activity Readiness Questionnaire) - if weight loss is contraindicated or might be impacted by a condition or medication (e.g., end stage renal disease, cancer, schizophrenia, dementia, steroids, anti-psychotics) - if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus) - investigator discretion for safety reasons

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Core Behavioral Weight Loss Intervention
All participants will receive a 10-week core behavioral weight loss treatment consisting of: self-monitoring weight, steps, and food intake; behavioral lessons; action plans; and tailored feedback. The intervention will be delivered remotely via email and digital tools (such as a smart scale, Fitbit activity tracker, and Fitbit app).
Easier Step Goal
Participants will receive an easier daily step goal.
Harder Step Goal
Participants will receive a more challenging daily step goal.
Easier Calorie Goal
Participants will receive an easier daily calorie goal.
Harder Calorie Goal
Participants will receive a more challenging daily calorie goal.
Easier Eating Window Goal
Participants will receive an easier daily eating window goal.
Harder Eating Window Goal
Participants will receive a more challenging daily eating window goal, akin to time-restricted eating.
Easier Red Zone Food Goal
Participants will receive an easier daily Red Zone Food goal.
Harder Red Zone Food Goal
Participants will receive a more challenging daily Red Zone Food goal.

Locations

Country Name City State
United States Stanford University School of Medicine Palo Alto California

Sponsors (2)

Lead Sponsor Collaborator
Stanford University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary (Feasibility) engagement in self-monitoring body weight average percentage of days in the 10-week intervention of self-monitoring weight (assessed objectively via smart scale); a benchmark of self-monitoring 75% of days would indicate feasibility baseline to 10 weeks
Primary (Feasibility) engagement in self-monitoring steps average percentage of days in the 10-week intervention of self-monitoring steps (assessed objectively via Fitbit activity tracker); a benchmark of self-monitoring 75% of days would indicate feasibility baseline to 10 weeks
Primary (Feasibility) engagement in self-monitoring dietary intake average percentage of days in the 10-week intervention of self-monitoring dietary intake (assessed via Fitbit mobile app); a benchmark of self-monitoring 75% of days would indicate feasibility baseline to 10 weeks
Primary (Acceptability) Would you recommend the weight loss program to a friend who is trying to lose weight? 1-item measure; a benchmark of 80% of participants answering "yes" would indicate acceptability 10 weeks
Secondary (Feasibility) retention rate the proportion of participants who submitted a weight entry at 10 weeks; a benchmark of 80% would indicate feasibility 10 weeks
Secondary (Feasibility) survey completion rate the proportion of participants who completed the web survey; a benchmark of 80% would indicate feasibility baseline; 10 weeks
Secondary (Feasibility) goal attainment of calorie goal average percentage of days in the 10-week intervention of meeting the daily calorie goal (assessed via Fitbit mobile app); a benchmark of 75% of days would indicate feasibility baseline to 10 weeks
Secondary (Feasibility) goal attainment of step goal average percentage of days in the 10-week intervention of meeting the daily step goal (assessed via Fitbit activity tracker); a benchmark of 75% of days would indicate feasibility baseline to 10 weeks
Secondary (Feasibility) goal attainment of eating window goal average percentage of days in the 10-week intervention of meeting the daily eating window goal (assessed via survey); a benchmark of 75% of days would indicate feasibility baseline to 10 weeks
Secondary (Feasibility) goal attainment of Red Zone Food goal average percentage of weeks in the 10-week intervention of meeting the weekly Red Zone Food goal (assessed via survey); a benchmark of 75% of weeks would indicate feasibility baseline to 10 weeks
Secondary weight change in weight from baseline to 10-week (end of intervention); assessed objectively via smart scale baseline to 10 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2